Synergistic Addition of Ligilactobacillus acidipiscis YJ5 to a Probiotic Consortium for Enhanced Alleviation of Loperamide‐Induced Constipation in Mice
Journal of Food Science · 2026
DOI: 10.1111/1750-3841.71332 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Food Science, 2026. Verfasst von Fei Shen und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Biological and Chemical Engineering, Zhejiang University of Science & Technology, Hangzhou, China. Hauptthemen laut MEDLINE: Probiotics, Loperamide, Constipation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Zhejiang Provincial Leading Geese Plan Projects, Zhejiang University of Science & Technology Scientific Research Development Fund Talent Launch Project.
Abstract (Originalsprache)
Probiotics have emerged as a promising therapeutic strategy for relieving constipation. The strategy of employing multi‐strain probiotic combinations to achieve synergistic therapeutic effects is widely adopted in commercial applications. This study demonstrates that incorporating Ligilactobacillus acidipiscis YJ5 as a synergistic keystone strain into a base three‐strain probiotic consortium (CP3‐L) creates a potent low‐dose formulation (CP4‐L) with enhanced efficacy against loperamide‐induced constipation in mice. Although the CP3‐L consortium ( Lactiplantibacillus plantarum SYS1 and T34, Limosilactobacillus fermentum W1) itself outperformed its constituent single strains, the CP4‐L consortium provided improvement in defecation parameters, intestinal barrier integrity, and inflammatory markers. It effectively restored interstitial cells of Cajal (ICC) markers (c‑Kit/SCF) to enhance intestinal motility, downregulated colonic aquaporins to increase fecal water content, and selectively modulated the gut microbiota to raise beneficial Bifidobacterium and fecal butyrate levels. These findings validate a mechanism‐guided approach to probiotic consortium design, where functional complementarity between strains yields synergistic, multi‐target anti‐constipation activity at a reduced dosage.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Biological and Chemical Engineering, Zhejiang University of Science & Technology, Hangzhou, China.
- College of Biosystems Engineering and Food Science, Zhejiang University, Hangzhou, China.
- Beingmate Co., Ltd, Hangzhou, China.
- Hangzhou Kangyuan Food Science & Technology Co., Ltd., Hangzhou, China.
- College of Food Science and Technology, Zhejiang University of Technology, Hangzhou, China.
ORCID-Profile: Congguo Wei, Hao Zhong
Förderung
- National Natural Science Foundation of China
- Zhejiang Provincial Leading Geese Plan Projects
- Zhejiang University of Science & Technology Scientific Research Development Fund Talent Launch Project
Zitieren
APA
Shen, F., Wei, C., Zhang, Z., Zhou, Y., Han, Y., Du, J., Feng, F., He, G., & Zhong, H. (2026). Synergistic Addition of Ligilactobacillus acidipiscis YJ5 to a Probiotic Consortium for Enhanced Alleviation of Loperamide‐Induced Constipation in Mice. Journal of Food Science. https://doi.org/10.1111/1750-3841.71332
Vancouver
Shen F, Wei C, Zhang Z, Zhou Y, Han Y, Du J, et al. Synergistic Addition of Ligilactobacillus acidipiscis YJ5 to a Probiotic Consortium for Enhanced Alleviation of Loperamide‐Induced Constipation in Mice. Journal of Food Science. 2026. doi:10.1111/1750-3841.71332
BibTeX
@article{Shen2026,
author = {Shen, Fei and Wei, Congguo and Zhang, Zhiguo and Zhou, Yujie and Han, Yunjing and Du, Juan and Feng, Fengqin and He, Guanghua and Zhong, Hao},
title = {Synergistic Addition of Ligilactobacillus acidipiscis YJ5 to a Probiotic Consortium for Enhanced Alleviation of Loperamide‐Induced Constipation in Mice},
journal = {Journal of Food Science},
year = {2026},
doi = {10.1111/1750-3841.71332}
}
EUVIMED